P.Liuetal.ThemutationallandscapeofNSCLC
3.Horowitz,J.M.etal.(1990)Frequentinactivationoftheretinoblastoma
analysisshouldbeincludedinthefutureinvestigation.Second,dueto
anti-oncogeneisrestrictedtoasubsetofhumantumorcells.Proc.Natl
thenatureofnext-generationsequencingtechnology,someprotein-
Acad.Sci.USA,87,2775–2779.
codingregionscannotbecapturedinlibrarypreparationorby
4.Mori,N.etal.(1990)VariablemutationsoftheRBgeneinsmall-celllung
sequencingbecauseofregionsofhighGCcontent.Onlysomatic
carcinoma.Oncogene,5,1713–1717.
mutationsarecalledwhenbothtumorsandtheirmatchednormal
5.Yokomizo,A.etal.(1998)PTEN/MMAC1mutationsidenti?edinsmall
samplessimultaneouslyhavesuf?cientcoveragesatthosecoding
cell,butnotinnon-smallcelllungcancers.Oncogene,17,475–479.
regions.Forexample,mutationsinSTK11foundtobefrequently
6.Franklin,W.A.etal.(2002)Epidermalgrowthfactorreceptorfamilyinlung
mutatedinthepreviousstudy(8)werenotidenti?edinourstudy.
cancerandpremalignancy.Semin.Oncol.,29,3–14.
Third,theidenti?cationofasecondmajorcancergeneinNSCLCwill
7.Suzuki,Y.etal.(1990)Detectionofrasgenemutationsinhumanlung
furtherde?nethepathogenesisandgeneticarchitectureofthistumorcancersbysingle-strandconformationpolymorphismanalysisofpolymer-
asechainreactionproducts.Oncogene,5,1037–1043.
type.OurfunctionalstudyprovidedinitialevidenceofCSMD3con-
8.Ding,L.etal.(2008)Somaticmutationsaffectkeypathwaysinlungade-
tributingtolungtumorigenesis.Understandingthecontributionof
nocarcinoma.Nature,455,1069–1075.
CSMD3mutationtotumorinitiationaswellasdiseaseprogression
9.Lee,W.etal.(2010)Themutationspectrumrevealedbypairedgenome
andoutcomeareimportantfutureareasoflungcancerresearch.
sequencesfromalungcancerpatient.Nature,465,473–477.
10.Pleasance,E.D.etal.(2010)Asmall-celllungcancergenomewithcomplex
signaturesoftobaccoexposure.Nature,463,184–190.
Supplementarymaterial
11.Meyerson,M.etal.(2010)Advancesinunderstandingcancergenomes
throughsecond-generationsequencing.Nat.Rev.Genet.,11,685–696.
SupplementaryTables1–17andFigures1–5canbefoundathttp://
12.Li,H.etal.(2010)Fastandaccuratelong-readalignmentwithBurrows-
carcin.oxfordjournals.org/
Wheelertransform.Bioinformatics,26,589–595.
13.Koboldt,D.C.etal.(2009)VarScan:variantdetectioninmassivelyparallel
Funding
sequencingofindividualandpooledsamples.Bioinformatics,25,2283–
2285.
ThisworkwassupportedbyNationalInstitutesofHealthgrants
14.Ng,S.B.etal.(2009)Targetedcaptureandmassivelyparallelsequencingof
R01CA129533(MY),R01CA113793(MY),R01CA134682(MY,
12humanexomes.Nature,461,272–276.
PL),R01CA80127(PY),R01CA84354(PY);theAdvancingaHealth-
15.Li,Y.etal.(2010)Resequencingof200humanexomesidenti?esanexcess
ierWisconsinChemopreventionProgram(PI:MY);andtheMayo
oflow-frequencynon-synonymouscodingvariants.Nat.Genet.,42,969–
FoundationFund(PY).972.
16.Oishi,Y.etal.(2010)MutationanalysisoftheSDHBandSDHDgenesin
pheochromocytomasandparagangliomas:identi?cationofanovelnon-
Acknowledgements
sensemutation(Q168X)intheSDHBgene.Endocr.J.,57,745–750.
17.Lu,H.etal.(2008)GRIM-19isessentialformaintenanceofmitochondrial
WethankBruceW.EckloffandEricD.WiebenoftheSequencingCoreatthe
membranepotential.Mol.Biol.Cell,19,1893–1902.
MayoClinicfortechnicalassistance,andHarisVikisandJayTichelaarfor
18.Muro,S.etal.(2001)EffectofPCCBgenemutationsontheheteromeric
readingandcommentingonthemanuscript.
andhomomericassemblyofpropionyl-CoAcarboxylase.Mol.Genet.
Metab.,74,476–483.
Con?ictofInterestStatement:Nonedeclared.
19.Sun,Y.etal.(2009)DepletionofPI3Kp.85alphainducescellcyclearrest
andapoptosisincolorectalcancercells.Oncol.Rep.,22,1435–1441.
20.Wei,X.etal.(2011)Exomesequencingidenti?esGRIN2Aasfrequently
mutatedinmelanoma.Nat.Genet.,43,442–446.
References
21.Levine,A.etal.(2006)TheP53pathway:whatquestionsremaintobe
1.Siegel,R.etal.(2011)Cancerstatistics,2011:theimpactofeliminatingexplored?CellDeathDiffer.,13,1027–1036.
22.Harris,S.etal.(2005)Thep53pathway:positiveandnegativefeedback
socioeconomicandracialdisparitiesonprematurecancerdeaths.CACan-
loops.Oncogene,24,2899–2908.
cerJ.Clin.,61,212–236.
2.Wistuba,I.I.etal.(2001)Moleculargeneticsofsmallcelllungcarcinoma.
ReceivedJanuary16,2012;revisedMarch28,2012;acceptedApril6,2012
Semin.Oncol.,28,3–13.
7
1276
ViewpublicationstatsViewpublicationstats |
|
